Rui Tato Marinho

9.7k total citations · 1 hit paper
116 papers, 1.4k citations indexed

About

Rui Tato Marinho is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Rui Tato Marinho has authored 116 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hepatology, 64 papers in Epidemiology and 28 papers in Surgery. Recurrent topics in Rui Tato Marinho's work include Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (39 papers) and Hepatitis B Virus Studies (27 papers). Rui Tato Marinho is often cited by papers focused on Hepatitis C virus research (39 papers), Liver Disease Diagnosis and Treatment (39 papers) and Hepatitis B Virus Studies (27 papers). Rui Tato Marinho collaborates with scholars based in Portugal, United States and United Kingdom. Rui Tato Marinho's co-authors include José Velosa, Edward Tam, João Sanches, Fernando Ramalho, Miguel Carneiro de Moura, Fred Poordad, Heiner Wedemeyer, Marc Bourlière, Junyuan Xiong and Barry Bernstein and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rui Tato Marinho

98 papers receiving 1.4k citations

Hit Papers

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvi... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Tato Marinho Portugal 17 968 960 173 141 82 116 1.4k
Clara Milikowski United States 15 1.7k 1.8× 1.4k 1.4× 109 0.6× 242 1.7× 61 0.7× 51 2.6k
Marcello Maida Italy 26 933 1.0× 823 0.9× 237 1.4× 585 4.1× 170 2.1× 165 2.4k
Jie Peng China 23 1.1k 1.1× 1.0k 1.1× 215 1.2× 147 1.0× 19 0.2× 115 1.8k
Yee‐Kit Tse Hong Kong 30 2.3k 2.4× 1.9k 2.0× 201 1.2× 242 1.7× 28 0.3× 87 2.7k
Keiichi Fujiwara Japan 26 1.2k 1.2× 1.5k 1.6× 338 2.0× 211 1.5× 14 0.2× 123 1.9k
Woo Jin Chung South Korea 26 958 1.0× 895 0.9× 138 0.8× 609 4.3× 52 0.6× 113 2.4k
S. Bowden United Kingdom 22 713 0.7× 568 0.6× 184 1.1× 57 0.4× 261 3.2× 58 1.9k
Guillaume Pénaranda France 28 1.5k 1.6× 1.6k 1.6× 298 1.7× 525 3.7× 33 0.4× 120 2.7k
Kentaro Matsuura Japan 22 729 0.8× 699 0.7× 83 0.5× 77 0.5× 20 0.2× 88 1.2k
Walid S. Ayoub United States 21 1.1k 1.1× 992 1.0× 51 0.3× 388 2.8× 25 0.3× 65 2.0k

Countries citing papers authored by Rui Tato Marinho

Since Specialization
Citations

This map shows the geographic impact of Rui Tato Marinho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Tato Marinho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Tato Marinho more than expected).

Fields of papers citing papers by Rui Tato Marinho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Tato Marinho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Tato Marinho. The network helps show where Rui Tato Marinho may publish in the future.

Co-authorship network of co-authors of Rui Tato Marinho

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Tato Marinho. A scholar is included among the top collaborators of Rui Tato Marinho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Tato Marinho. Rui Tato Marinho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freitas, Carlos Clayton Macedo de, Miguel Carneiro de Moura, Pedro Russo, et al.. (2024). Comparison of the efficacy and safety of endoscopic management of fistulas after bariatric surgery with the Luso-Cor and conventional covered metallic stents. Endoscopy. 56(S 02). S103–S103.
2.
Ferreira, Carlos Noronha, et al.. (2024). Multimodal Endoscopic Management of Fistula after Sleeve Gastrectomy Involving a Novel Esophageal Stent. GE Portuguese Journal of Gastroenterology. 32(3). 205–211.
3.
Ferreira, Carlos Noronha, Daniela Reis, Carolina Simões, et al.. (2023). Clinical Efficacy and Safety of a Novel Stent for Fistula Management Following Sleeve Gastrectomy. Techniques and Innovations in Gastrointestinal Endoscopy. 26(1). 12–20. 2 indexed citations
4.
Bernardo, Sónia, et al.. (2022). Primary Diffuse Large B-Cell Lymphoma of the Rectum in a Non-Immunosuppressed Patient with Ulcerative Colitis. GE Portuguese Journal of Gastroenterology. 30(4). 305–310. 1 indexed citations
5.
Ezeonwumelu, Ifeanyi Jude, Verónica Briz, Victor Pimentel, et al.. (2022). Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide. PLoS ONE. 17(12). e0276618–e0276618. 1 indexed citations
6.
Ismail, Muhammad, et al.. (2022). Refractory benign esophageal strictures � To cut or to dilate?. Revista Española de Enfermedades Digestivas. 115(4). 206–207.
7.
Ferreira, Carlos Noronha, et al.. (2022). Detection and Characterization of Early Gastric Cancer. Frontiers in Oncology. 12. 855216–855216. 6 indexed citations
8.
9.
Ferreira, Carlos Noronha, Rui Tato Marinho, Helena Cortez‐Pinto, et al.. (2019). Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study. Liver International. 39(8). 1459–1467. 57 indexed citations
10.
Marinho, Rui Tato, et al.. (2019). Psychosocial and Neurocognitive Factors Associated With Hepatitis C – Implications for Future Health and Wellbeing. Frontiers in Psychology. 9. 2666–2666. 23 indexed citations
11.
Asselah, Tarik, Christophe Hézode, Neddie Zadeikis, et al.. (2016). ENDURANCE-4: Efficacy and Safety of ABT-493/ABT-530 Treatment in Patients with Chronic HCV Genotype 4, 5, or 6 Infection. Hepatology. 63. 7 indexed citations
12.
Marinho, Rui Tato, et al.. (2011). Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.. PubMed. 36(2). 110–8. 6 indexed citations
13.
Marinho, Rui Tato, et al.. (2011). GE - Jornal Português de Gastrenterologia, 2011. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 18(3). 114–115. 2 indexed citations
14.
Vanness, David J., Floortje van Nooten, Kosh Agarwal, et al.. (2010). 1029 COST-EFFECTIVENESS ANALYSIS OF THE EASL 2009 CLINICAL PRACTICE GUIDELINES FOR MANAGEMENT OF CHRONIC HEPATITIS B IN FRANCE, ITALY, PORTUGAL, SPAIN, TURKEY AND THE UNITED KINGDOM. Journal of Hepatology. 52. S398–S398. 2 indexed citations
15.
Marinho, Rui Tato, et al.. (2008). Hepatite auto-imune no idoso: A propósito de um caso clínico. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 15(5). 215–219. 1 indexed citations
16.
Marinho, Rui Tato, et al.. (2007). Doença de Caroli segmentar em homem de 73 anos. 14(1). 22–25.
17.
Marinho, Rui Tato. (2007). Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005). World Journal of Gastroenterology. 13(10). 1522–1522. 11 indexed citations
18.
Marinho, Rui Tato, et al.. (2000). Hepatite a: alteração do padrão epidemiológico. SHILAP Revista de lepidopterología. 16(2). 1 indexed citations
19.
Marinho, Rui Tato, et al.. (1998). Vacinação contra a hepatite B. Oito anos de experiência.. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Ramalho, Fernando, et al.. (1992). [Viral infections in intravenous drug addicts. Clinical and prognostic significance].. PubMed. 4(5). 263–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026